Thermo Fisher Scientific Nears Deal To Buy PPD For More Than $15 Bln : Report

Thermo Fisher Scientific Inc. (TMO) is nearing a deal to buy pharmaceutical-testing company PPD Inc. (PPD) for more than $15 billion, the Wall Street Journal reported citing people familiar with the matter.

The companies could finalize a deal as soon as this week, assuming the talks don't fall apart, the report said.

Wilmington, North Carolina-based PPD, with a market cap around $15.09 billion, is a contract-research company, running drug trials for pharma companies as well as providing lab services.

PPD closed Monday regular trading at $43.00 up $4.64 or 12.10%. In the after-hours trade, the stock further gained $1.10 or 2.56%.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
PepsiCo, Inc. (PEP) has reached an agreement with private equity firm PAI Partners to sell Tropicana, Naked and other select juice brands across North America. The agreement also includes an irrevocable option to sell certain juice businesses in Europe. The combined pre-tax cash proceeds will be approximately... Drug major Eli Lilly And Co. reported Tuesday weak profit in its second quarter, despite higher revenues driven by strong volume across core business and most major geographies. Further, the company trimmed its forecast for fiscal 2021 earnings on a reported basis and margin, while maintained adjusted earnings view above market estimates. The company also tightened full-year revenue forecast. Shares of BMW Group were losing around 5 percent in German trading after the luxury automaker warned Tuesday that its second half-year is likely to be more volatile, affected by supply bottlenecks, high prices for raw materials and a shortage of semiconductors. This was despite reporting strong second-quarter results driven by solid demand.
Follow RTT